This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The University of New Mexico. Active years: 2014-2017.
Location History:
- Brentford, GB (2014)
- Middlesex, GB (2017)
Company Filing History:
Years Active: 2014-2017
Title: Anatoliy Markiv: Innovator in Fluorescent Fusion Polypeptides
Introduction
Anatoliy Markiv is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fluorescent fusion polypeptides. With a total of 2 patents to his name, Markiv's work has implications for immunofluorescence analysis.
Latest Patents
Markiv's latest patents focus on the generation of stable recombinant fusion polypeptides with intrinsic fluorescent properties. These innovations provide a method for creating recombinant antibodies that are suitable for both qualitative and quantitative immunofluorescence analysis. The fluorescent polypeptides consist of a fluorescent domain with a C-terminus and an N-terminus, along with two antibody domains covalently linked to these termini.
Career Highlights
Throughout his career, Anatoliy Markiv has worked with various organizations, including Stc.unm and Unm Rainforest Innovations. His experience in these companies has allowed him to refine his expertise in the field of biotechnology and contribute to groundbreaking research.
Collaborations
Markiv has collaborated with notable professionals in his field, including Ravi Durvasula and Angray Singh Kang. These partnerships have further enhanced his research and development efforts.
Conclusion
Anatoliy Markiv is a distinguished inventor whose work in fluorescent fusion polypeptides has the potential to advance immunofluorescence analysis significantly. His contributions to biotechnology are noteworthy and continue to influence the field.